Sangamo BioSciences Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
24,133.00
45,870.00
39,539.00
19,389.00
36,567.00
84,452
SG&A Expense
50,110.00
71,872.00
85,337.00
90,951.00
91,430.00
157,143
EBIT
26,546.00
26,551.00
46,786.00
72,559.00
56,361.00
75,050
Unusual Expense
160.00
230.00
70.00
-
-
2,100
Non Operating Income/Expense
-
-
431.00
-
-
-
Pretax Income
26,624.00
26,417.00
46,425.00
71,672.00
54,568.00
68,889
Income Tax
-
-
5,722.00
14.00
-
-
Consolidated Net Income
26,624.00
26,417.00
40,703.00
71,658.00
54,568.00
68,889
Net Income
26,624.00
26,417.00
40,703.00
71,658.00
54,568.00
68,334
Net Income After Extraordinaries
26,624.00
26,417.00
40,703.00
71,658.00
54,568.00
68,334
Net Income Available to Common
26,624.00
26,417.00
40,703.00
71,658.00
54,568.00
68,334
EPS (Basic)
0.48
0.39
0.58
1.02
0.70
0.70
Basic Shares Outstanding
55,974.00
67,022.00
69,757.00
70,553.00
78,084.00
96,941
EPS (Diluted)
0.48
0.39
0.58
1.02
0.70
0.70
Diluted Shares Outstanding
55,974.00
67,022.00
69,757.00
70,553.00
78,084.00
96,941
EBITDA
25,977.00
26,002.00
45,798.00
71,562.00
54,863.00
72,691
Non-Operating Interest Income
82.00
364.00
-
887.00
1,793.00
8,261
About Sangamo BioSciences
View Profile
